Table 3. Correlation between the absolute number of eosinophils and other clinical relevant parameters at diagnosis.
| Parameter | Univariate analysis p value |
Multivariate analysis p value |
|---|---|---|
| Skin lesions y/n | 0.214 | – |
| Darier's sign y/n | 0.386 | – |
| Sex female/male | 0.022 | 0.655 |
| Kit pos/neg | 0.006 | 0.385 |
| CD2 y/n | 0.691 | – |
| CD25 y/n | 0.146 | – |
| Organomegaly y/n | <0.0001 | 0.021 |
| Dysmyelopoiesis y/n | 0.019 | 0.016 |
| Ascites y/n | <0.0001 | 0.771 |
| Portal hypertension y/n | 0.052 | – |
| Malabsorption y/n | 0.001 | 0.198 |
| Weight loss y/n | <0.0001 | 0.289 |
| Mediator symptoms y/n | 0.369 | – |
| Allergies y/n | 0.871 | – |
| WHO classification | 0.004 | 0.001 |
| R/p value | ||
| Age | 0.024/0.240 | – |
| Tryptase (ln)a | 0.02/0.416 | – |
| WBC (ln) a | 0.263/<0.0001 | <0.0001 |
| Hemoglobin | 0.006/0.775 | – |
| Platelets (ln)a | 0.028/0.174 | – |
| Alkaline phosphatase (ln)a | 0.061/0.008 | 0.092 |
| LDH (ln) | 0.031/0.184 | – |
Bold face: factors that remained significant in multivariate analysis y/n yes/no
a
ln: to compensate for asymmetric distribution, data were logarithmized